Christopher P. Karch
Impact in
- Virology top 10%
- HIV Research and Treatment
-
- Immunotherapy and Immune Responses
Papers in
-
- vaccines and immunoinformatics approaches 3
- RNA Interference and Gene Delivery 2
-
- Immunotherapy and Immune Responses 7
- Co-authors
- Peter Burkhard (13 shared papers)Sara M. Paulillo (4 shared papers)David E. Lanar (3 shared papers)Gary R. Matyas (6 shared papers)Zeinab H. Helal (3 shared papers)Zoltán Beck (5 shared papers)Mazhar I. Khan (2 shared papers)Stephen A. Kaba (1 shared paper)
- Journals
- Nanomedicine Nanotechnology Biology and Medicine (3 papers)Biochemical and Biophysical Research Communications (1 paper)The FASEB Journal (1 paper)Expert Review of Vaccines (1 paper)PLoS ONE (1 paper)
- Partner nations
- United StatesEgyptBurkina Faso
In The Last Decade
Christopher P. Karch
18 papers receiving 503 citations
Peers
Comparison fields: 5 of 59
- Virology 44
- Immunology 179
- Infectious Diseases 126
- Radiology, Nuclear Medicine and Imaging 105
- Parasitology 31
Countries citing papers authored by Christopher P. Karch
This map shows the geographic impact of Christopher P. Karch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher P. Karch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher P. Karch more than expected).
Fields of papers citing papers by Christopher P. Karch
This network shows the impact of papers produced by Christopher P. Karch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher P. Karch. The network helps show where Christopher P. Karch may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher P. Karch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 181 | |
| 2 | 2016 | 51 | |
| 3 | 2017 | 45 | |
| 4 | 2017 | 43 | |
| 5 | 2013 | 36 | |
| 6 | 2017 | 31 | |
| 7 | 2018 | 28 | |
| 8 | 2018 | 22 | |
| 9 | 2020 | 18 | |
| 10 | 2021 | 11 | |
| 11 | 2018 | 10 | |
| 12 | 2010 | 8 | |
| 13 | 2018 | 8 | |
| 14 | 2021 | 7 | |
| 15 | 2020 | 4 | |
| 16 | 2017 | 3 | |
| 17 | 2020 | 2 | |
| 18 | 2019 | 2 |
About Christopher P. Karch
Christopher P. Karch is a scholar working on Molecular Biology, Immunology, Ecology, Radiology, Nuclear Medicine and Imaging and Virology, having authored 18 papers that have together received 510 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Bacteriophages and microbial interactions (5 papers), HIV Research and Treatment (4 papers), vaccines and immunoinformatics approaches (3 papers), Cancer, Hypoxia, and Metabolism (2 papers), Toxoplasma gondii Research Studies (2 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Virology (44 citations), Immunology (179 citations), Infectious Diseases (126 citations), Radiology, Nuclear Medicine and Imaging (105 citations) and Parasitology (31 citations). Christopher P. Karch has collaborated with scholars based in United States, Egypt and Burkina Faso. Frequent co-authors include Peter Burkhard, Sara M. Paulillo, David E. Lanar, Gary R. Matyas, Zeinab H. Helal, Zoltán Beck, Mazhar I. Khan, Stephen A. Kaba, Sharareh Emadi and Muhammad Abubaker Khan. Their work appears in journals such as Nanomedicine Nanotechnology Biology and Medicine, Biochemical and Biophysical Research Communications, The FASEB Journal, Expert Review of Vaccines and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.